Injectable meloxicam has been registered for use in sheep to alleviate pain and inflammation. It is already registered for use in dogs, cats, pigs, cattle and horses.
The approval comes following a joint submission from Boehringer Ingelheim in Australia, New Zealand and Canada that saw regulatory agencies from each country participate in a collaborative review process. The regulatory agencies for each country maintained the right to determine whether a product was approved for its own market. The joint submission and simultaneous review also marks an important achievement in international regulatory cooperation.
Meloxicam is a non-steroidal anti-inflammatory drug of the oxicam class. In sheep, the product (Metacam® 20) is given as a single subcutaneous injection of 1.0mL/20kg bodyweight from 2 weeks of age.
The AVA’s sheep special interest group took a keen interest in the registration process, providing comments on the application during the public consultation phase.
“We were very keen to see a safe and effective treatment for pain and inflammation in sheep, and we see real value in meloxicam to help manage the effects of painful husbandry procedures,” said Bruce Watt, President of Australian Sheep Veterinarians.
“ASV requested a change in the label relating to withholding periods for dairy sheep, and we are very pleased that our recommended change was made. This will improve the practical usefulness of the product.”